Warts Liquid
NDC Package 55714-4849-1
Package Information
Warts (antimon. crud., bryonia, calc.carb., causticum, dulcamara, graphites, lycopodium, merc. sulph. rub., nat. carb., nitricum ac., nux vom., rhus toxicodendron, sabina, sepia, silicea, staphysag., sulphur, thuja occ., taraxacum) liquids is formulated for moist, cauliflower-like skin growths, warty growths, skin eruptions, fig warts and smooth warts. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4849.
Identification & Billing
Clinical Specifications
- ANTIMONY TRISULFIDE 15 [hp_X]/mL
- BRYONIA ALBA ROOT 15 [hp_X]/mL
- CAUSTICUM 15 [hp_X]/mL
- DELPHINIUM STAPHISAGRIA SEED 15 [hp_X]/mL
- GRAPHITE 15 [hp_X]/mL
- JUNIPERUS SABINA LEAFY TWIG 15 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 15 [hp_X]/mL
- MERCURIC SULFIDE 15 [hp_X]/mL
- NITRIC ACID 15 [hp_X]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 15 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 15 [hp_X]/mL
- SILICON DIOXIDE 15 [hp_X]/mL
- SODIUM CARBONATE 15 [hp_X]/mL
- SOLANUM DULCAMARA TOP 15 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 15 [hp_X]/mL
- SULFUR 15 [hp_X]/mL
- TARAXACUM OFFICINALE 6 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG 15 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 15 [hp_X]/mL
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-4849 - Warts
- 55714-4849-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-4849 - Warts
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-4849-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Warts, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains antimony trisulfide; bryonia alba root; causticum; delphinium staphisagria seed; graphite; juniperus sabina leafy twig; lycopodium clavatum spore; mercuric sulfide; nitric acid; oyster shell calcium carbonate, crude; sepia officinalis juice; silicon dioxide; sodium carbonate; solanum dulcamara top; strychnos nux-vomica seed; sulfur; taraxacum officinale; thuja occidentalis leafy twig; toxicodendron pubescens leaf as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on December 19, 2022. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714484901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.